Genome British Columbia
Genome British Columbia is a research organization that invests in and manages large-scale genomics and proteomics research projects and science and technology platforms focused on areas of strategic importance such as human health, forestry, fisheries, ethics, agriculture, and the environment. By working collaboratively with all levels of government, universities and industry, Genome BC is the catalyst for a vibrant, genomics-driven life sciences cluster with far reaching social and economic benefits for the province and Canada.
Personalized Medicine is a focus for Genome BC funded through the Translational Program in Applied Health and the soon to be launched Personalized Medicine Demonstration Program.
Genome BC's major investors are Genome Canada and the Province of British Columbia. This funding is complemented by other private and public investments.
Established in 2000, Genome BC is one of six Genome Canada centers across the country.